Chairman's
Speech for AGM 2006
Ladies and Gentlemen:
It is a pleasure to welcome you
to this the forty-eighth annual general meeting.
Let me begin by asking you a
simple question. When I mention the word
"teens", what are the thoughts that cross
your mind? It could be anything, ranging from courage,
energy, freshness, new-age, innovative.
Let's hold on to this string of
thought as I take you through last year's
performance and GSKCH's targets for 2007.
I am delighted to be able to tell
you that 2006 was another year of outstanding
performance and double-digit growth. In 2006, we
experienced growth across all regions. We were not
only able to grow in terms of sales, but also
managed to strengthen some of our existing brands
through innovative strategies. We displayed
dexterity in keeping costs under check and utilising
existing resources to the optimum. Your company
truly emerged as an innovative player in the FMCG
industry.
2007 promises to be yet another
exciting year. Having experienced two consecutive
years of double digit growth, we now wish to take
"growth" to a new level. Clearly, double
digit growth today is not enough, and therefore no
longer the benchmark. We now need to be much more
innovative and to think bigger.
According to Steve Jobs, the
co-founder of Apple Inc., "Innovation
distinguishes between a leader and a follower."
We need to innovate in order to emerge as a true
leader in the Indian FMCG market. That leadership
will only come by stepping up our innovation
processes and taking more calculated risks. To help
focus our team on what is required, we have a new
motto - 'performance with an edge'.
'Climbing the Teens'
Looking ahead, we must keep up
the momentum of 2005 and 2006 in order to achieve
our key objective for this year - to finally 'climb
up the teens' in terms of growth rates. In order
to fulfil this target, we need to have a fresh and
vibrant approach to growth. We need to move beyond
best practices, to 'next practices' that will
help us take the 'next leap forward'.
When the economy is on a roll,
growth comes easy. It is certainly not a cause of
concern. However, to move up further, our
performance will need to have that cutting edge over
our competitors. That edge will come from
innovation, and our
continued endeavours to look for new growth segments
and by strengthening our existing portfolio.
High economic growth is throwing
up new opportunities. GSKCH is excited by the
opportunities ahead and has an aggressive long-term
strategy for growth and leadership. In this
connection we are exploring all kinds of
opportunities in the health and wellness (nutraceuticals)
space in India.
Nutraceuticals is our way of
touching the lives of consumers spread across the
length and breadth of the country. With rising
awareness and health-consciousness, this new-age
category is attracting a lot of attention. Your
company also has the technological expertise and
competencies, the brand equity, and all the required
formats to address the country's health, nutrition
and wellness needs.
Nutraceuticals will be our key
focus for 2007. We have undertaken several
innovative initiatives in the past that have been
successful with consumers - such as putting up
vending machines at schools, offices, hospitals etc
for Horlicks and Boost; introducing Horlicks Lite, a
lifestyle management solution for 40+ adults and
launching Mother's Horlicks with DHA.
Recently, we also kicked off an
exam stress management activity called ' Horlicks
Bhoot Bhagao' in
14 cities. This initiative helped kids prepare
better for exams. We also provided parents, teachers
and principals with an 'Exam Time Tips' booklet on
how to support children practically and emotionally
during exam time. In 2007, we hope to see more of
such innovative initiatives that will further boost
brand
GSK.
The senior management of GSKCH is
constantly taking a pulse check on the market. In
2007, GSKCH will look for both organic and inorganic
means of growth. We have initiated a programme for
targeted acquisitions in India. We would like to
acquire healthcare brands, technologies or
businesses that will support our growth agenda. Your
company has the complete support of the board to
explore and leverage opportunities that are a
strategic fit for growth.
The stage is set to help us
achieve our goals. The economy is growing at a
healthy rate of over 9%. Both the FMCG industry and
the organised retail industry are growing at even
more healthy rates of 20% and 45% respectively.
Economic growth projections are
also on our side. The $13.1 billion FMCG sector is
poised to treble in value terms by 2018. Penetration
levels in most product categories continue to be
quite low, giving us the opportunity to exploit the
burgeoning wealth of the Indian middle class and to
turn "growth' into "explosive
growth". We can't ask for a better business
environment.
A stellar performance
2006 saw sales increase by 11.5%
whereas the bottom-line registered a growth of
18.4%. This was despite the fact that input costs
rose by 9% over last year. Amongst the items
affected by cost increases were liquid milk and
skimmed milk powder - two very important
ingredients for our products. In 2006, north India
witnessed 20% less rainfall. This coupled with
higher temperatures in the north and floods in West
India during July and August, adversely impacted
milk and skimmed milk powder (SMP) supply across the
country.
What played as a double whammy
were volatile international prices for most
commodities. Adverse weather conditions in America,
Europe and Australia resulted in reduced world grain
output, which in turn lead to increased market
volatility. The net result for us was an
unprecedented increase in prices of SMP (40%), wheat
(22%), milk (23%). For those of you who know our
production processes you would understand how this
impacted our business.
Our procurement team was
proactive in managing the crisis-situation in milk
and SMP and maintained security of supply for all
manufacturing sites. Various cross-functional
initiatives in sugar, SMP, malt and gluten have been
taken up that will ensure supplies at competitive
rates. Moreover, savings arising out of a well
executed in-house cost containment programme have
led to a healthy bottom-line growth.
In the year ended December 31,
2006, GSKCH posted a sales turnover of Rs. 1214
Crore, against Rs. 1089 Crore in 2005. Profit after
tax stood at Rs. 127 Crore, as against Rs. 107 Crore
for 2005.
As you can see, your company was
successful in achieving an impressive top line,
while keeping costs at the lowest possible level.
And we didn't achieve that by cutting down our
advertising budgets or sales and marketing spends,
but by reducing operating costs. Today, we operate
with minimum trade pipelines. We are able to sell as
per the market demand and maintain a very efficient
supply chain.
2006 was clearly the year of
Horlicks. The 136-year old brand, restaged last
year, clocked an impressive 12.8% growth thanks to
some intense market research and product
development. Innovation worked wonders. For
instance, some attractive, state-of-the-art
packaging for Junior Horlicks and the relaunch of
Chocolate Horlicks in a cold format were some
innovative ideas we introduced last year. Chocolate
Horlicks on the back of 'Icy' froze the
competition stiff and delivered a resounding 22%
growth. Junior Horlicks 'Jingled' its way in to
the hall of fame with a 21% growth.
Besides being cost-conscious and
innovative, we were also able to improve our cash
management. We maximised return on idle cash through
efficient investment in debt-based mutual funds.
During 2006, we also launched a state-of-the-art
web-based Treasury operation integrating payments to
vendors and collections from customers, centrally.
Changes in top management
There have been changes in the
top leadership that I am sure you are aware of.
Having expressed a desire to spend more time in UK
with his family, towards the end of last year, Nick
Massey returned to a senior position with GSK in
London. It would be remiss of me if I did not take
this opportunity to place on record our appreciation
of the way he managed the business during his time
here. With effect from January 1, 2007, Zubair Ahmed
has taken charge as the Managing Director. Zubair
comes to us with 30 years of experience gained from
working with large companies like Voltas, Unilever
and Gillette. In the past, Zubair has taken on a
number of very exciting and challenging assignments,
and I am confident that he will provide a fresh
thrust and perspective to our growth agenda. I am
confident that under his leadership, GSKCH will
scale new heights and see many innovative strategies
in products and processes. So, Zubair, welcome. We
are all looking forward to working with you.
In addition, two directors on the
GSKCH board - P Dwarakanath and A S Lakshmanan -
retired last year. While P Dwarakanath continues to
be a non-executive director, A S Lakshmanan had
reached the age limit which we have set for board
members. I am particularly sad to see Laksh leave
our board. I have served with him on a number of the
company's boards In India, and during that time
apart from being a colleague, he was a friend.
Partha S Mukherjee, another
whole-time director, left the services of the
company in May 2006, and whilst not remaining as a
director, has agreed to continue to represent our
company's interests at the various chamber and
government committees he sits on.
Although your company is going
through a number of changes at the top, we should
all view this transition phase positively. Under
Zubair and the team, I am sure the core values of
the company will only grow stronger, as we carry on
our quest for higher and higher growth.
Community partnership
Your company, in its endeavour to
serve the community, continues to contribute to
rural areas around its factories. Last year, many of
our CSR initiatives won global recognition and
awards.
During 2006, we won the
prestigious Asian CSR 2006 Award, in the category of
"Improvement of Education", for our work
on the "knowledge-based therapeutic recreation
for children/youth and HIV/AIDS" programme in
India. The programme was chosen out of a highly
competitive field of 178 projects submitted by 98
companies across 14 countries in Asia. It
acknowledged the company's leadership in raising
awareness in girl children about their rights
against trafficking and sensitising them about
hygiene and appropriate behaviour when dealing with
People Living With AIDS (PLWA).
During the year the Nabha site
received "The Best Environment Protection
Initiative 2006" award from the Punjab
Pollution Control Board. The site proactively
launched the 'Stop Dengue' Campaign in Nabha
town to improve sanitation and hygiene, in
association with local NGOs, civil administration
and health authorities and the community.
Like before, the site organised
regular animal welfare measures and subsidised vet
medicines, supported several dairy farming
initiatives like veterinary camps, milking
competitions, sponsoring awareness camps etc in the
milk shed area.
We also launched new CSR
initiatives in 2006. In Sonepat, a multifaceted
programme for health and education of women was
undertaken. Under this programme, health camps and
vocational training programmes were organised in
order to empower the rural womenfolk. This effort is
the stepping stone for many such initiatives in
villages around your factory in Sonepat.
Apart from external CSR
activities, your company is concerned with doing
what it can for a cleaner and safer environment.
Over the last two years, the Rajahmundry site has
planted more than 2000 Bio-diesel saplings. The
bio-diesel accrued from these plants shall be used
for the vehicles operated by the site.
We have everything going for us
today. The boom and the thrust on the retail sector
augur well for our industry. Investments in certain
infrastructure projects in the last six years have
opened up new opportunities in semi-urban and rural
areas. Higher literacy rates, changes in lifestyle,
increased health consciousness, and mass media
promotion are some of the major contributors to the
growing demand of consumer products in the country.
In conclusion, I am sure you will
join me in extending our appreciation to everybody
who worked at making 2006 such a stellar year for
the company. In 2007, we hope to keep up with the
indomitable spirit of GSK and navigate the company
to the next level of growth. In Pope John Paul II's
words "We need the enthusiasm of the young. We
need their joie
de vivre."
At the next AGM, I hope to announce an even more
spectacular performance, where we can target a
performance 'beyond the teens'. With a strong
will and the GSK spirit, I am sure no target is
beyond our reach.
Dividend payout
Before I close, I have one final
item to cover. This is the dividend payout. Like our
focused attention on growth, maximising shareholder
value is important to us. To enhance returns to
shareholders, your Board of Directors declared an
Interim dividend aggregating to Rs. 10 per share
that is commensurate with the results for the year
ended 31st December, 2006.
Thank you.
|